Inovise Medical
PrivateLast Round
Accelerator
Jun 15, 2021
Total Funding Raised
$23.42M
Company Overview
Inovise Medical operates in Healthcare & Life Sciences and is based in Beaverton, Oregon. Its latest recorded funding round was an Accelerator round in June 2021.
Inovise Medical is a medical technology company that develops diagnostic solutions for cardiac care, including the Audicor heart failure management system.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inovise Medical Comparables
Compare Inovise Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HD Medical, Inc. | 84% | |
| Sensydia | 83% | |
| VoluMetrix | 82% |
For institutional investors. Book with your work email.
Inovise Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 15, 2021 | ||||
| M&A | Feb 1, 2017 | ||||
| VC Round | Sep 6, 2012 | ||||
| VC Round | Feb 16, 2011 | ||||
| Early Funding | Jul 9, 2009 | ||||
Series B Extension | Jan 29, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inovise Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gabelli Funds | Series B Extension |
| MedTech Innovator | Accelerator |
| Cardiac Science, Inc. | Series D |
| CHL Medical Partners | Series B Extension |
| DFO Management | Series B Extension |
| TAT Capital Partners, Ltd. | Series D |
| MDS Capital Corp. | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2021
Received funding from MedTech Innovator.
- Feb 1, 2017
Raised M&A round with VisCardia, Inc.
For institutional investors. Book with your work email.
Inovise Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inovise Medical's valuation, stock price, and market status.
Is Inovise Medical a public or private company?
Inovise Medical is a private company.
What is the current stock price of Inovise Medical?
Inovise Medical is a private company, so its shares have no public market price. Caplight tracks Inovise Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inovise Medical worth (valuation)?
Valuation information for Inovise Medical is not publicly available.
Can I buy Inovise Medical stock?
Inovise Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inovise Medical's last funding round?
Inovise Medical's most recent funding round was Accelerator on June 15, 2021.
Who are the main investors in Inovise Medical?
Key investors in Inovise Medical include TAT Capital Partners, Ltd., MDS Capital Corp..
Will Inovise Medical IPO soon?
No public IPO plans have been announced for Inovise Medical.
How can I track Inovise Medical secondary market activity?
Caplight tracks bids, offers, and trades in Inovise Medical's shares on secondary markets.